Literature DB >> 18241619

Adiponectin and cardiovascular inflammatory responses.

Yukihiro Takemura1, Kenneth Walsh, Noriyuki Ouchi.   

Abstract

Obesity is recognized as a cause of many metabolic and cardiovascular disorders through its ability to promote chronic systemic inflammation. Recent studies have found that adipose tissues secrete numerous cytokines that are referred to as adipokines. Although most adipokines induce inflammation, adiponectin inhibits inflammatory reactions and protects against metabolic and cardiovascular diseases. This review focuses on the anti-inflammatory properties of adiponectin in various experimental systems, especially with respect to cardiovascular diseases.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18241619     DOI： 10.1007/s11883-007-0025-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  51 in total

1.  Different effects of adiponectin isoforms in human monocytic cells.

Authors:  Markus Neumeier; Johanna Weigert; Andreas Schäffler; Gabriele Wehrwein; Ulf Müller-Ladner; Jürgen Schölmerich; Christian Wrede; Christa Buechler
Journal:  J Leukoc Biol       Date:  2006-01-24       Impact factor: 4.962

2.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

3.  Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats.

Authors:  Y Hattori; K Akimoto; S S Gross; S Hattori; K Kasai
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

4.  Adiponectin-mediated modulation of hypertrophic signals in the heart.

Authors:  Rei Shibata; Noriyuki Ouchi; Masahiro Ito; Shinji Kihara; Ichiro Shiojima; David R Pimentel; Masahiro Kumada; Kaori Sato; Stephan Schiekofer; Koji Ohashi; Tohru Funahashi; Wilson S Colucci; Kenneth Walsh
Journal:  Nat Med       Date:  2004-11-21       Impact factor: 53.440

5.  Adiponectin replenishment ameliorates obesity-related hypertension.

Authors:  Koji Ohashi; Shinji Kihara; Noriyuki Ouchi; Masahiro Kumada; Koichi Fujita; Aki Hiuge; Toshiyuki Hibuse; Miwa Ryo; Hitoshi Nishizawa; Norikazu Maeda; Kazuhisa Maeda; Rei Shibata; Kenneth Walsh; Tohru Funahashi; Iichiro Shimomura
Journal:  Hypertension       Date:  2006-05-01       Impact factor: 10.190

6.  Implications of plasma concentrations of adiponectin in patients with coronary artery disease.

Authors:  Y Nakamura; K Shimada; D Fukuda; Y Shimada; S Ehara; M Hirose; T Kataoka; K Kamimori; S Shimodozono; Y Kobayashi; M Yoshiyama; K Takeuchi; J Yoshikawa
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

7.  Adiponectin and protection against type 2 diabetes mellitus.

Authors:  Joachim Spranger; Anja Kroke; Matthias Möhlig; Manuela M Bergmann; Michael Ristow; Heiner Boeing; Andreas F H Pfeiffer
Journal:  Lancet       Date:  2003-01-18       Impact factor: 79.321

8.  Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR.

Authors:  G Chinetti; C Zawadski; J C Fruchart; B Staels
Journal:  Biochem Biophys Res Commun       Date:  2004-01-30       Impact factor: 3.575

9.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin.

Authors:  Christopher Hug; Jin Wang; Naina Shehzeen Ahmad; Jonathan S Bogan; Tsu-Shuen Tsao; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

Review 10.  Obesity, adiponectin and vascular inflammatory disease.

Authors:  Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa; Kenneth Walsh
Journal:  Curr Opin Lipidol       Date:  2003-12       Impact factor: 4.776
View more
  17 in total

1.  Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats.

Authors:  Ruiqian Wan; Ismayil Ahmet; Martin Brown; Aiwu Cheng; Naomi Kamimura; Mark Talan; Mark P Mattson
Journal:  J Nutr Biochem       Date:  2009-05-07       Impact factor: 6.048

2.  Lack of association between adiponectin levels and atherosclerosis in mice.

Authors:  Andrea R Nawrocki; Susanna M Hofmann; Daniel Teupser; Joshua E Basford; Jorge L Durand; Linda A Jelicks; Connie W Woo; George Kuriakose; Stephen M Factor; Herbert B Tanowitz; David Y Hui; Ira Tabas; Philipp E Scherer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

Review 3.  Podocytopathy in diabetes: a metabolic and endocrine disorder.

Authors:  Ana Diez-Sampedro; Oliver Lenz; Alessia Fornoni
Journal:  Am J Kidney Dis       Date:  2011-06-29       Impact factor: 8.860

4.  Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation.

Authors:  Jason M Konter; Jennifer L Parker; Elizabeth Baez; Stephanie Z Li; Barbara Ranscht; Martin Denzel; Frederic F Little; Kazuto Nakamura; Noriyuki Ouchi; Alan Fine; Kenneth Walsh; Ross S Summer
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

5.  T-cadherin is essential for adiponectin-mediated revascularization.

Authors:  Jennifer L Parker-Duffen; Kazuto Nakamura; Marcy Silver; Ryosuke Kikuchi; Ulrich Tigges; Sumiko Yoshida; Martin S Denzel; Barbara Ranscht; Kenneth Walsh
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

6.  Adiponectin protects rat hippocampal neurons against excitotoxicity.

Authors:  Guang Qiu; Ruiqian Wan; Jingping Hu; Mark P Mattson; Edward Spangler; Shan Liu; Suk-Yu Yau; Tatia M C Lee; Marc Gleichmann; Donald K Ingram; Kwok-Fai So; Sige Zou
Journal:  Age (Dordr)       Date:  2010-09-15

7.  The aporphine alkaloid boldine induces adiponectin expression and regulation in 3T3-L1 cells.

Authors:  Bangning Yu; Carla Cook; Nalini Santanam
Journal:  J Med Food       Date:  2009-10       Impact factor: 2.786

Review 8.  Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.

Authors:  Stephane Heymans; Emilio Hirsch; Stefan D Anker; Pal Aukrust; Jean-Luc Balligand; Jan W Cohen-Tervaert; Helmut Drexler; Gerasimos Filippatos; Stephan B Felix; Lars Gullestad; Denise Hilfiker-Kleiner; Stefan Janssens; Roberto Latini; Gitte Neubauer; Walter J Paulus; Burkert Pieske; Piotr Ponikowski; Blanche Schroen; Heinz-Peter Schultheiss; Carsten Tschöpe; Marc Van Bilsen; Faiez Zannad; John McMurray; Ajay M Shah
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

Review 9.  Metabolic Messengers: Adiponectin.

Authors:  Leon G Straub; Philipp E Scherer
Journal:  Nat Metab       Date:  2019-03-14

10.  Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions?

Authors:  Ross Summer; Kenneth Walsh; Benjamin D Medoff
Journal:  Pulm Circ       Date:  2011 Oct-Dec       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.